디팔미토일 하이드록시프롤린을 함유하는 튼살 완화용화장료 조성물
    111.
    发明公开
    디팔미토일 하이드록시프롤린을 함유하는 튼살 완화용화장료 조성물 有权
    化妆品组合物对含有DIPALMITOYL羟脯氨酸的皮肤进行抗标记

    公开(公告)号:KR1020090022599A

    公开(公告)日:2009-03-04

    申请号:KR1020070088104

    申请日:2007-08-31

    CPC classification number: A61K8/4913 A61K8/44 A61K8/97 A61K36/23 A61Q19/00

    Abstract: A cosmetic composition for striae distensae is provided to secure skin lifting and wrinkle improvements through dipalmitoyl hydroxyproline used as an ingredient. A cosmetic composition for striae distensae comprises dipalmitoyl hydroxyproline as an active ingredient. The cosmetic composition additionally includes one ingredient selected from a Centella Asiatica extract and Palmitoyl PG-Linoleamide. The content of the dipalmitoyl hydroxyproline is 0.001-50wt% on a total weight basis of the cosmetic composition. The contents of the Centella Asiatica extract and the Palmitoyl PG-Linoleamide are 0.001-20wt% on the total weight basis of the cosmetic composition.

    Abstract translation: 提供了一种用于纹状细胞的化妆品组合物,以通过用作成分的二棕榈酰羟脯氨酸来确保皮肤起皱和皱纹的改善。 用于条纹的化妆品组合物包括二棕榈酰羟脯氨酸作为活性成分。 化妆品组合物另外包括选自积雪草提取物和棕榈酰PG-亚油酰胺的一种成分。 二棕榈酰羟脯氨酸的含量为化妆品组合物的总重量的0.001-50重量%。 积雪草提取物和棕榈酰PG-亚油酰胺的含量相对于化妆品组合物的总重量为0.001-20重量%。

    셀루릭서를 함유하는 항노화용 조성물
    112.
    发明公开
    셀루릭서를 함유하는 항노화용 조성물 有权
    包含细胞的抗老化组合物

    公开(公告)号:KR1020070079889A

    公开(公告)日:2007-08-08

    申请号:KR1020060010935

    申请日:2006-02-04

    Abstract: An anti-aging composition is provided to effectively prevent skin aging through free-radical scavenging, inhibition of LDH secretion caused by UV and inhibition of MMP-1 secretion, and show excellent skin permeability and excellent stability without skin side effects. The anti-aging composition comprises at least two materials selected from the group consisting of argan oil, carnosine such as L-carnosine, and an extract of corn which is prepared by using an extraction solvent such as water and 1,3-butylene glycol, wherein the selected at least two materials are encapsulated into cyclodextrin.

    Abstract translation: 提供抗衰老组合物,以通过自由基清除,抑制由UV引起的LDH分泌和抑制MMP-1分泌来有效预防皮肤老化,并且显示出优异的皮肤渗透性和优异的稳定性,而没有皮肤副作用。 所述抗衰老组合物包含选自由甘油,焦肌氨酸,L-肌肽等的至少两种材料和通过使用提取溶剂如水和1,3-丁二醇制备的玉米提取物, 其中所选择的至少两种材料被包封成环糊精。

    제니스테인 또는 다이드제인을 함유하는 각질형성세포의식작용 억제용 피부외용제 조성물
    113.
    发明公开
    제니스테인 또는 다이드제인을 함유하는 각질형성세포의식작용 억제용 피부외용제 조성물 无效
    皮肤外用组合物,用于抑制含有大黄酸或大黄酸的卡那霉素的PHAGOCYTOSIS抑制

    公开(公告)号:KR1020070014672A

    公开(公告)日:2007-02-01

    申请号:KR1020050069506

    申请日:2005-07-29

    Abstract: A skin external composition for inhibiting phagocytosis of keratinocytes comprising genistein or daidzein is provided to reduce mobility of melanosomes transferred from melanocytes in keratinocytes by inhibiting phagocytosis of keratinocytes activated by exposure to ultra violet ray without cytotoxicity, so that chloasma, freckles and speckles are treated and prevented. The skin external composition for inhibiting phagocytosis of keratinocytes comprises at least one selected from genistein and daidzein, wherein the amount of genistein or daidzein is 0.0001-10 wt.%; the genistein or daidzein is an isoflavone produced from Leguminosae plants and shows estrogen effects; and the composition is formulated as cream, lotion, ointment, aqueous solution, suspension, dispersion or emulsion.

    Abstract translation: 提供了一种用于抑制包含染料木黄酮或黄豆苷原的角质形成细胞吞噬作用的皮肤外用组合物,以通过抑制通过暴露于紫外线而没有细胞毒性活化的角质形成细胞的吞噬作用来降低角质形成细胞中从黑素细胞转移的黑素体的移动性,从而处理黄褐斑,雀斑和斑点 预防。 用于抑制角化细胞吞噬的皮肤外用组合物包含选自染料木黄酮和黄豆苷原中的至少一种,其中染料木黄酮或黄豆苷原的量为0.0001-10重量%; 染料木素或黄豆苷原是由豆科植物产生的异黄酮,显示雌激素作用; 并将组合物配制成霜剂,洗剂,软膏,水溶液,悬浮液,分散体或乳液。

    피부 보습 및 피부 탄력 증진용 화장료 조성물
    114.
    发明公开
    피부 보습 및 피부 탄력 증진용 화장료 조성물 有权
    化妆品组合物,用于增湿效果,增强肌肤弹性

    公开(公告)号:KR1020070013481A

    公开(公告)日:2007-01-31

    申请号:KR1020050067814

    申请日:2005-07-26

    CPC classification number: A61K8/97 A61K2800/59 A61Q19/007

    Abstract: A cosmetic composition for moisturizing the skin and enhancing elasticity of the skin is provided to improve both of skin moisturizing and skin elasticity enhancement by increase of collagen in the dermis layer without side effects. The cosmetic composition for moisturizing the skin and enhancing elasticity of the skin comprises the SWEET nutritive complex containing Tilia europaea extract, Borago officinalis flower extract, wheat extract, sugar cane extract and orange extract, wherein the composition further comprises Oenothera odorata extract; the amount of the SWEET nutritive complex is 0.01-30 wt.% based on the total weight of the composition; and the amount of Oenothera odorata extract is 0.01-30 wt.% based on the total weight of the composition.

    Abstract translation: 提供了一种用于保湿皮肤和增强皮肤弹性的化妆品组合物,以通过增加真皮层中的胶原蛋白来改善皮肤保湿和皮肤弹性增强,而没有副作用。 用于保湿皮肤和增强皮肤弹性的化妆品组合物包括含有椴树提取物,硼草提取物,小麦提取物,甘蔗提取物和橙子提取物的SWEET营养复合物,其中所述组合物还包含欧烯酮提取物; 基于组合物的总重量,SWEET营养复合物的量为0.01-30重量%; 并且基于组合物的总重量,烯类气味提取物的量为0.01-30重量%。

    115.
    外观设计
    有权

    公开(公告)号:KR3009276240000S

    公开(公告)日:2017-10-24

    申请号:KR3020170017354

    申请日:2017-04-14

    Designer: 김지현

    메틸화된 카테킨을 유효성분으로 함유하는 FoxO3 유전자 활성화용 조성물
    117.
    发明公开
    메틸화된 카테킨을 유효성분으로 함유하는 FoxO3 유전자 활성화용 조성물 审中-实审
    包含用于激活FOXO3基因的甲基化CATECHIN的组合物

    公开(公告)号:KR1020160069739A

    公开(公告)日:2016-06-17

    申请号:KR1020140175702

    申请日:2014-12-09

    CPC classification number: A61K31/353 A61K8/49 A61Q19/08 Y02E50/30

    Abstract: 본명세서에는메틸기를포함하는카테킨, 이의염, 이의프로드럭, 이의수화물, 이의용매화물또는이의이성질체를유효성분으로함유하는 FoxO3 유전자활성화용조성물이개시된다. 일측면에서, 본명세서에개시된기술은 FoxO3 유전자를활성화함으로써 FoxO3 유전자와관련된염증성질환, 암, 항노화, 피부개선에유용한약학조성물, 화장료조성물또는식품조성물을제공하는효과가있다.

    Abstract translation: 在本发明中公开了一种组合物,其包含具有甲基的儿茶素,其盐,其前药,其水合物,其溶剂化物或其异构体作为活性成分,用于激活FoxO3基因。 在本发明的一个方面中公开了一种技术,其具有提供可用于皮肤改善,抗衰老,癌症,FoxO3基因相关的炎性疾病的药物组合物,化妆品组合物或食品组合物,其通过激活 FoxO3基因。

    메틸화된 카테킨을 유효성분으로 함유하는 ERCC8 유전자 활성화용 조성물
    118.
    发明公开
    메틸화된 카테킨을 유효성분으로 함유하는 ERCC8 유전자 활성화용 조성물 审中-实审
    包含用于激活ERCC8基因的甲基化CATECHIN的组合物

    公开(公告)号:KR1020160069738A

    公开(公告)日:2016-06-17

    申请号:KR1020140175701

    申请日:2014-12-09

    CPC classification number: A61K31/353 A61K8/49 A61Q19/08 Y02E50/30

    Abstract: 본명세서에는메틸기를포함하는카테킨, 이의염, 이의프로드럭, 이의수화물, 이의용매화물또는이의이성질체를유효성분으로함유하는 ERCC8 유전자활성화용조성물이개시된다. 일측면에서, 본명세서에개시된기술은 ERCC8 유전자를활성화함으로써 ERCC8 유전자와관련된항노화, 피부개선, 코케인증후군에유용한약학조성물, 화장료조성물또는식품조성물을제공하는효과가있다.

    Abstract translation: 在本发明中公开了包含具有甲基的儿茶素,其盐,其前药,其水合物,其溶剂化物或其异构体作为活性成分的组合物,用于激活ERCC8基因。 在本发明的一个方面中公开了一种技术,其具有通过激活ERCC8基因提供可用于Cockayne综合征,皮肤改善,ERCC8基因相关抗衰老的药物组合物,化妆品组合物或食品组合物的效果。

    메틸화된 카테킨을 유효성분으로 함유하는 Klotho 유전자 활성화용 조성물
    119.
    发明公开
    메틸화된 카테킨을 유효성분으로 함유하는 Klotho 유전자 활성화용 조성물 审中-实审
    包含用于激活KLOTHO基因的甲基化CATECHIN的组合物

    公开(公告)号:KR1020160069736A

    公开(公告)日:2016-06-17

    申请号:KR1020140175699

    申请日:2014-12-09

    CPC classification number: A61K31/353 A61K8/49 A61Q19/08 Y02E50/30

    Abstract: 본명세서에는메틸기를포함하는카테킨, 이의염, 이의프로드럭, 이의수화물, 이의용매화물또는이의이성질체를유효성분으로함유하는 Klotho 유전자활성화용조성물이개시된다. 일측면에서, 본명세서에개시된기술은 Klotho 유전자를활성화함으로써 Klotho 유전자와관련된항노화, 피부개선, 동맥경화, 골다공증, 뇌졸중, 알츠하이머에유용한약학조성물, 화장료조성물또는식품조성물을제공하는효과가있다.

    Abstract translation: 在本发明中公开了一种组合物,其包含具有甲基的儿茶素,其盐,其前药,其水合物,其溶剂合物或其异构体作为活性成分,用于激活Klotho基因。 在本发明的一个方面中公开了一种技术。 该技术在提供可用于阿尔茨海默氏病,中风,骨质疏松症,皮肤改善,通过激活Klotho基因的Klotho基因相关抗衰老,化妆品组合物或食物组合物的药物组合物方面具有效果。

    120.
    外观设计
    有权

    公开(公告)号:KR3008396390000S

    公开(公告)日:2016-02-18

    申请号:KR3020150029536

    申请日:2015-06-12

    Designer: 김지현

Patent Agency Ranking